PureTech Health Valuation
| PTCHF Stock | USD 1.85 0.00 0.00% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. PureTech Health plc holds a recent Real Value of $2.09 per share. The prevailing price of the company is $1.85. Our model determines the value of PureTech Health plc from analyzing the company fundamentals such as Operating Margin of (9.87) %, return on equity of -0.0152, and Shares Outstanding of 278.81 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that PureTech Health's price fluctuation is moderately volatile at this time. Calculation of the real value of PureTech Health plc is based on 3 months time horizon. Increasing PureTech Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PureTech pink sheet is determined by what a typical buyer is willing to pay for full or partial control of PureTech Health plc. Since PureTech Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PureTech Pink Sheet. However, PureTech Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.85 | Real 2.09 | Hype 1.85 |
The real value of PureTech Pink Sheet, also known as its intrinsic value, is the underlying worth of PureTech Health plc Company, which is reflected in its stock price. It is based on PureTech Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PureTech Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PureTech Health plc helps investors to forecast how PureTech pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PureTech Health more accurately as focusing exclusively on PureTech Health's fundamentals will not take into account other important factors: About PureTech Health Valuation
The pink sheet valuation mechanism determines PureTech Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of PureTech Health. We calculate exposure to PureTech Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PureTech Health's related companies.PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 95 people.
8 Steps to conduct PureTech Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PureTech Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PureTech Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain PureTech Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PureTech Health's revenue streams: Identify PureTech Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PureTech Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish PureTech Health's growth potential: Evaluate PureTech Health's management, business model, and growth potential.
- Determine PureTech Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PureTech Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
PureTech Health Growth Indicators
Investing in growth stocks can be very risky. If the company such as PureTech Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 287.8 M | |
| Quarterly Earnings Growth Y O Y | 0.615 | |
| Retained Earnings | 199.9 M |
Complementary Tools for PureTech Pink Sheet analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |